Podocytes injury • The ALL1-fused from the chromosome 1q (AF1q) • Wnt/β-catenin signaling • Chronic kidney diseases (CKD) • Adriamycin (ADR) Abstract Background/Aims: Injury of podocytes plays an important role in decline of glomerular filtration and proteinuria. It is well-known that proteinuria is associated with numerous chronic kidney diseases (CKD). However, the underlying mechanism of podocyte injury remains unclear. Methods: We used reverse transcription-quantitative PCR (RT-qPCR) to compare the expression level of the ALL1-fused from the chromosome 1q (AF1q) gene in mice and mouse podocytes (MPC5) with or without Adriamycin (ADR) treatment. The effects of AF1q on Wnt/ β-catenin signaling were investigated by determining the expressions of desmin, snail, WT1, nephrin and E-cadherin using western blotting. Results: We found that AF1q expression was elevated in podocytes treated with ADR than untreated cells. AF1q overexpression directly led to podocytes injury with increased levels of desmin and snail. Luciferase activity of TOPflash reporter was significantly increased in cells with AF1q overexpression than wild type cells whereas deletion of T-cell-factor-7 (TCF7) eliminated this effect. Immunoprecipitation assay evidenced that AF1q interacted with TCF7 and promoted both transcriptional and translational expressions of TCF7. Overexpression of AF1q increased protein expression of β-catenin. However, in podocytes with deletion of TCF7, AF1q was not able to promote β-catenin expression. Conclusion: Our findings demonstrated that aberrant expression of AF1q may activate Wnt/β-catenin signaling and result in podocyte injury.
Introduction
Podocytes are highly differentiated perivascular cells developed from embryonic precursor mesenchymal cells [1] . In the kidney, they form an elaborate cytoarchitecture with regularly spaced and interdigitated foot processes surrounding the glomerular capillaries, which plays an essential role in maintaining the integrity and function of the glomerular filtration barrier (GFB) [2] . Thus, injury of podocytes may result in defective glomerular filtration and is the main cause of proteinuria [3] . A number of chronic kidney diseases (CKD) at early stage exhibit proteinuria [4] . Additionally, podocyte injury has been evidenced as a key factor in the pathogenesis of proteinuria that occurs in majority of patients with CKD [4] . Mutations of several genes encoding proteins such as nephrin and podocin that are involved in the establishment of GFB leads to the development of proteinuria [5] . However, in clinical CKD cases, few patients are identified with these mutations and the mechanism of podocyte injury remains unclear.
Wnt gene family encodes secreted glycoproteins participating in a series of biological processes such as cell growth and differentiation. Canonical Wnt/β-catenin signaling was first identified in Drosophila and is evolutionally conserved in all metazoans. It has a critical role in the development of kidney development. However, it is commonly silenced in adult kidney [6] . Recently, increasing studies have reported the correlation between Wnt/β-catenin signaling and podocyte injury [7] . Nuclear translocation of β-catenin was enhanced by administration of puromycin to podocytes [8] . Wang D et al. demonstrated that Adriamycin (ADR) or transforming growth factor-β (TGF-β) are involved in activation of Wnt/β-catenin signaling and results in podocyte injury and proteinuria [9] . In fact, ADR nephropathy was established and has been long applied as an experimental model of kidney disease such as glomerulosclerosis [10, 11] . Although ADR increases the level of reactive oxygen species and stimulates Wnt signaling, it has been demonstrated that the main contributions of ADR to kidney injury are mutations in mitochondrial DNA and decrease of it copy number [12] . Additionally, the Wilms' tumor suppressor gene (Wt1) that is limitedly expressed in the podocytes of adult kidney was reported to modulate Wnt/β-catenin signaling and consequently cause podocyte dysfunction and apoptosis [13] . Therefore, a clear understanding of Wnt signaling may be essential for development of efficient treatment of CKD.
The ALL1-fused from the chromosome 1q (AF1q) gene is discovered from acute myeloid leukemia (AML) patients and restrictedly expressed in the differentiation of T-cells [14] . Although no studies have investigated the roles of AF1q in kidney, it was recently reported that AF1q could stimulate Wnt signaling by directly binding to T-cell-factor-7 (TCF7) [15] . In present study, we aimed to investigate whether AF1q participates in the pathogenesis of podocytes injury and its underlying mechanism.
Materials and Methods

Mice
Podocyte injury of BALB/c mice weighing 20-24 g and aged 6 weeks was induced by ADR as previously described [16] . Mice were treated with ADR for 3, 6 or 12 days and then sacrificed to obtain glomeruli (n=5 each group). For testing the effects of AF1q on kidney in vivo, mice were injected with vector or Flag-AF1q via tail vein using hydrodynamics-based procedure (1.8 ml per mouse) as previously stated [17] . After 24 h, ADR (10.5 mg/kg Doxorubicin hydrochloride; Sigma, St. Louis, MO, USA) was administrated via intravenous injection. Sieving technique was used to isolate the glomeruli from kidney as previously described [18] . This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of Daqing Oil Field General Hospital.
Cell and treatment
Conditionally immortalized mouse podocytes (MPC5) were cultured in RPMI-1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% v/v fetal bovine serum (FBS, Gibco, Grand Island, NY) at 33 °C and 5% CO 2 with 10 U/ml of interferon-γ (BioSource, Waltham, MA) and differentiated at 37 °C (without interferon-γ) supplemented with 10% v/v FBS. After differentiation for 10-14 days, the podocytes were treated with ADR (3 μg/ml) for 6 h, 12 h and 24 h. Flag-AF1q and shTCF7 were constructed for overexpression of AF1q and deletion of TCF7, respectively. Additionally, HEK-293T cell line (BIOLEAF, China) was cultured in Dulbecco's modified Eagle's medium (DMEM) supplied with 10% v/v FBS (Sigma) and 1% v/v streptomycin and penicillin at 37 o C in a humidified incubator with 5% CO 2 .
Reverse transcription-quantitative PCR (RT-qPCR)
RNA was extracted using TRIzol reagent (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Reverse cDNA synthesis was performed using a cDNA synthesis kit (Promega, Madison, WI, USA) according to the instructions of the manufacturer. Primers used in RT-qPCR for detecting AF1q and TCF7 are as following: AF1q forward, 5'-TCAGATACAGCCACCTAC-3'; Reverse, 5'-TAGAGCAAGTCCATGTCG-3'; TCF7 forward 5'-TGCCTTGGACTCTGCTTGTG -3'; Reverse, 5'-CGTCTACTCCGGCTTCAATCTG -3'. Values were normalized to GAPDH. GAPDH forward, 5'-CCTCGTCCCGTAGACAAAATG-3'; reverse, 5'-TCTCCACTTTGCCACTGCAA-3'. The relative quantity of the products was calculated as follow: RQ=1/E Cq Western blotting Cells were lysed by RIPA buffer (Thermo Fisher Scientific, Waltham, MA). Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was used for separating proteins. Proteins were transferred onto a nitrocellulose membrane (Millipore, Billerica, MA, USA). The primary antibodies (1:1000 diluted in tris-buffered saline with 0.1% tween, TBST) were used to detect desmin (Sigma), snail (Sigma), WT1 (Sigma), nephrin (Sigma), E-cadherin (Sigma), tubulin (Sigma), Flag (Sigma), β-catenin (Abcam, Cambridge, MA), myc tag (Abcam), TCF7 (Abcam).
Hematoxylin and eosin (HE) staining
Renal sample was placed in 10% neutral-buffered formalin fixative at room temperature for 12 hour and embedded in paraffin. Then, samples were stained by hematoxylin and eosin (HE).
Luciferase assay
The effect of AF1q on Wnt/ β-catenin signaling was detected using a TOPflash reporter plasmid with TCF binding site upstream of the thymidine kinase (TK) minimal promoter and luciferase open reading frame (Millipore, USA). For transfection, TOP-flash plasmid and an internal control reporter plasmid (0.1 μg) Renilla reniformis luciferase driven under the TK promoter (pRL-TK; Promega, USA) were simultaneously transfected in cells. Luciferase activity was measured using a dual luciferase assay system kit (Promega, Madison, WI) according to the manufacturer's protocols and was observed by a Synergy H1 microplate reader (Biotek, Vermont, USA).
Statistical analysis
All data were presented as mean ± SD (standard deviation). Statistical analysis of the data was performed using GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA). Values of p<0.05 were considered as statistically significant. All experiments were performed at least 3 times.
Results
AF1q expression is upregulated in injured podocytes
To test whether AF1q is related to ADR-induced kidney injury, BALB/C mice were treated with ADR (10.5 mg/kg) by a tail vein injection. Mice were sacrificed on day 3, 6 or 12 after ADR treatment and glomeruli were isolated to evaluate AF1q mRNA level. We found that the transcriptional level of AF1q in glomeruli was significantly elevated in mice with ADR treatment compared with it in untreated mice (Fig. 1A) . We further validated this result in MPC5 cell line. As shown in Fig. 1B , both 1 µg/ml and 3 µg/ml ADR elicited remarkably increases of AF1q mRNA expression. When MPC5 cells were treated with 3 µg/ml ADR for 6, 12 and 24 h, AF1q mRNA level was enhanced with duration of treatment whereas no change was observed in untreated cells (Fig.  1C) . To clarify the function of AF1q in ADR-induced kidney injury, we established a AF1q-knockdown MPC5 cell line which were then treated by ADR (3 µg/ml) for 12h. We found that podocyte damage was not induced by ADR in the absence of AF1q (Fig. 2) . (Fig.  3A) . On the contrary, the expression levels of WT1, nephrin and E-cadherin as three podocyte functional markers were markedly repressed by AF1q. Then, HE staining results showed that mice with AF1q overexpression exhibited tubular dilation or deformation, and accompanied by glomerular hypertrophy in kidney compared to control mice (Fig. 3B) , indicating that AF1q aggravated podocyte injury and renal damage.
AF1q plays a role in podocyte injury and renal damage
To determine whether AF1q is related to podocyte injury, the protein levels of desmin and snail, two markers of podocyte injury, were compared between control and AF1q overexpressing cells. We observed that AF1q led to significant increases of protein expressions of desmin and snail in comparison with control
The function of AF1q on kidney is mediated by Wnt/β-catenin signaling
We then investigated the signaling pathway involved in AF1q-induced changes in kidney. It was observed that TOPflash reporter activity (luciferase reporter containing 3 optimal TCF binding sites) in AF1q overexpressed cells was significantly higher than it in control cells (Fig. 4A) . Protein level of β-catenin was comparably enhanced by AF1q (Fig. 4B) , suggesting that Wnt/ β-catenin signaling may be involved in AF1q-induced kidney injury.
AF1q enhances TCF7 expression and interacts with TCF7 in vitro
It was reported that AF1q enhanced Wnt signaling pathway by interacting with TCF7 to activate CD44 transcription [15] . We further confirmed the interactions between AF1q and TCF7. As shown in Fig. 5 A and B, myc-TCF7 was immunoprecipitated by Flag-AF1q using anti-Flag antibody and vice versa. Additionally, AF1q overexpression in 293T cells resulted in significant increase of TCF7 mRNA expression compared to control cells (Fig. 5C) . Fig. 2 . ADR-mediated podocyte damage would not occur in the absence of AF1q. MPC5 cells transfected with shCON or shAF1q were treated with CON or ADR (3μg/ml) for 12 h. mRNA levels of desmin, snail, nephrin, E-cadherin or WT1 were evaluated by Realtime PCR.
Knockdown of TCF7 eliminates the increase of β-catenin induced by AF1q
To further confirm the underlying mechanism of the effects of AF1q on Wnt signaling pathway, we tested the TOPflash reporter activity in TCF7 knockdown MPC5 cells. As expected, in TCF7 knockdown cells, no significant difference was observed between cells with or without AF1q transfection (Fig.  6A) . However, AF1q transfection led to a significantly higher level of TOPflash reporter activity than un-transfected cells in control cells without deletion of TCF7. Moreover, AF1 overexpression also increased protein expression of β-catenin whereas this effect was eliminated after TCF7 knockdown (Fig.  6B) .
Discussion
Under pathophysiologic conditions, the responses of podocytes to consistent stressors such as glomerular hyperfiltration and hypertension may comprise a spectrum of changes including hypertrophy, detachment, dedifferentiation, mesenchymal transition, mitotic catastrophe, and apoptosis [19] . Such changes may elicit dysfunction of podocytes and proteinuria. Thus, alleviation of these symptoms is essential for the treatment and several medicines have been found. Albuminuria was reported to be reduced by olmesartan through the inhibitory role of olmesatan in podocyte apoptosis [20] . Sinomenine was reported to repress autophagy of podocyte, which could prevent podocyte depletion [21] . However, new medicines are necessary for efficient treatment and detailed mechanism of podocytes injury needs to be revealed. Proteinuria is not only a marker for the progression of kidney injury but also mediates subsequent inflammatory responses. In adults, Wnt expression and signaling are normally silenced in the kidney. Sustained activation of Wnt signaling is critical in the pathogenesis of podocyte Tubulin. β-catenin expression was normalized to Tubulin. The relative expressions of these proteins were also shown. Data were presented as mean±SD. *p<0.05, **p<0.01. n.s indicates no statistical difference. dysfunction and proteinuria. Thus, understanding the mechanism of activation of Wnt signaling in podocytes is necessary.
Here, we found that transcriptional levels of AF1q were significantly higher in the glomeruli from ADR-treated mice than untreated mice. In vitro evidence in MPC5 cells also supported this observation, suggesting that AF1q may play a role in podocyte injury. By testing several markers of podocyte injury and function including desmin, snail, WT1, nephrin and E-cadherin, we demonstrated that high level of AF1q is associated with podocyte injury and dysfunction. Wnt/β-Catenin Signaling was reported to induce snail and repress nephrin expressions, indicating an adverse effect of Wnt signaling on podocyte function [22] . Recently, Park J et al. reported AF1q promotes metastasis of breast cancer via specifically binding to TCF7 in the Wnt signaling [15] . Based on the important role of Wnt in kidney, we investigated whether AF1q regulates Wnt signaling. We found that AF1q promoted the protein expression of β-catenin and interacted with TCF7. However, AF1q failed to enhance luciferase activity of TOPflash reporter and protein expression of β-catenin in TCF7 deleted cells. It is implied that AF1q regulates Wnt signaling via specifically binding to TCF7.
There are two Wnt/β-catenin signaling pathways, canonical and noncanonical signaling. In previous studies, activation of β-catenin has been observed in podocytes of various proteinuric CKD [23] . Thus, under CKD condition, it appears that Wnt signaling is mainly activated by canonical pathway, which is dependent on β-catenin. Briefly, after binding of Wnt family to their receptor Frizzled and coreceptors LRP5/6, several events occur in downstream signaling involving a number of proteins including Disheveled, axin, and glycogen synthase kinase-3β. Eventually these events stabilize β-catenin via dephosphorylation of β-catenin and translocate it to nuclei where it binds to TCF to activate transcriptions of Wnt target genes. In our results, overexpression of AF1q also elicited elevated expression of β-catenin. However, this effect may be indirect because we found that AF1q specifically binds to TCF7. It was demonstrated that AF1q promotes transcriptional rates through increasing the formation of transcriptional complex with lymphoid enhancer-binding factor (LEF) and β-catenin [15] . Additionally, we found that TCF7 transcriptional level was also increased by AF1q. Therefore, it is possible that AF1q promotes the formation of complex with TCF7 and also β-catenin, which in turn enhances TCF7 transcription. It was reported that inhibition of Wnt/β-catenin signaling ameliorates podocyte dysfunction, proteinuria, and kidney injury after using paricalcitol (19-nor-1, 25-hydroxy-vitamin D2) [24] .
The AF1q gene was originally identified in leukemia cells as a fusion partner for MLL protein and is highly expressed in leukemic and immature hematopoietic cells [14] . However, in normal hematopoietic tissue, its expression is mainly restricted in thymus. Several other tissues such as colon, small intestine, and ovary showed AF1q expression. We identified that the expression of AF1q was dramatically elevated in glomeruli from mice treated with ADR. The interaction between AF1q and Notch signaling was reported in the commitment intrathymic projenitros toward the T-cell lineage [25] . In recent years, the role of AF1q in neuronal cells has been confirmed by identification of AF1q spatiotemporal expression in brain and the ability of AF1q in transforming human embryonic kidney (HEK) cells into neuron-like cells [26, 27] . Although the biological function of AF1q has not been completely characterized, there are increasing evidence showed a potential proto-oncogenic function of AF1q in numerous tumors such as breast cancer and testicular germ cell tumors [28] [29] [30] . Based on these previous studies and the findings in our results, it is possible that there is a potential correlation between kidney disease and cancers because high expression of AF1q may both elicit cancers and kidney diseases. However, it also depends on the sites of aberrant AF1q expression. In 2013, Malkawi A et al. performed a retrospective study and demonstrated that glomerular filtration rate is related to survival of patients with AML [31] . It is hard to explain the reason for this observation but AF1q may affect the function of GFB and sequentially influence glomerular filtration rate. It is well known that acute renal failure is a common complication of patients with cancers by either the disease itself or treatment [32] [33] [34] . Additionally, CKD was reported to be a risk factor for lung and urinary tract cancers in older people [35] . Women with CKD was shown to have a higher frequency of breast calcification than women without CKD [36] . However, it is necessary to obtain a deeper insight into the roles of AF1q in CKD, which may provide a therapeutic method for treatment of CKD or cancers.
Conclusion
We identified that AF1q expression was elevated in podocytes treated with ADR. AF1q overexpression directly led to podocytes injury with elevated levels of desmin and snail. The function of AF1q was dependent on its interaction withTCF7.
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